Since its inception, the CHVI has made important progress on a number of fronts. Some of the key successes of the CHVI include:
The Government of Canada has committed $51 million since 2007 on CHVI programs.
The Government of Canada is investing up to $111 million in the CHVI and the Bill & Melinda Gates Foundation is contributing up to $28 million.
There are many steps on the road to an HIV vaccine from basic lab research, to developing a candidate vaccine, to testing it in regulated clinical trials, to finally getting it approved for use.
First established in 2007, the renewed CHVI will now be implementing new activities until 2017.
Supporting HIV prevention is essential while continuing to progress towards the goal of developing a safe and effective HIV vaccine.
For readers interested in the PDF version, the document is available for download or viewing:
The Canadian HIV Vaccine Initiative (CHVI) highlights our country's world-class HIV and vaccine research expertise. The CHVI Research and Development Alliance is the cornerstone of the renewed CHVI, and will enable Canada to be a leading contributor to global efforts in developing a safe effective, affordable and globally accessible HIV vaccine.
A collaboration between the Government of Canada and the Bill & Melinda Gates Foundation, the CHVI is Canada's contribution to the Global HIV Vaccine Enterprise. The Government of Canada partners in the CHVI are the Public Health Agency of Canada, the Canadian International Development Agency (CIDA), Health Canada, the Canadian Institutes of Health Research, and Industry Canada.
There are many steps on the road to an HIV vaccine from basic lab research, to manufacturing a potential vaccine, to testing it in clinical trials with solid regulatory and ethical oversight, to finally getting it approved for use.
The Government of Canada's investment in the CHVI Research and Development Alliance complements our efforts to address the spread of HIV and AIDS in Canada and globally. The Alliance will facilitate the advancement of the science that will lead us towards the ultimate goal of an HIV vaccine.
In July 2010, at the XVIII International AIDS Conference in Vienna, Austria, the Government of Canada and the Bill & Melinda Gates Foundation renewed their commitment of up to $139 million to implement the Canadian HIV Vaccine Initiative. Funding will be available until 2017.
Since the CHVI was established in 2007, a total of $51 million has been committed to support domestic and international research; improve collaboration among researchers in Canada and around the world; and enhance capacity for vaccine trials, policy development and community engagement.
The overall breakdown of the CHVI funds is as follows:
The Government of Canada, through CIDA, is investing in the prevention of mother-to child transmission, primarily in low- and-middle-income countries. As the development of an HIV vaccine will take time, it is important to continue to support global HIV prevention to reduce global HIV infection rates.
These investments aim to enhance access, quality and uptake of services by determining innovative and effective implementation strategies and programming solutions to help overcome barriers to service delivery. This may help pave the way for the introduction and acceptance of an HIV vaccine when it becomes available.
The Government of Canada and the Bill & Melinda Gates Foundation are supporting the establishment of a new CHVI Research and Development Alliance.
The CHVI Research and Development Alliance is a network in Canada that brings together leading researchers from the public and private sectors, as well as the international community, to develop innovative solutions to the challenges facing HIV vaccine development.
The Alliance will:
The key areas of focus for the Alliance will be:
An Advisory Board will provide governance and oversight to the Alliance and other HIV prevention activities. The role of the Advisory Board is to provide recommendations on projects to be funded to CHVI Ministers and the Bill & Melinda Gates Foundation and to oversee the implementation of the Alliance.
At the heart of the Alliance is the Alliance Coordinating Office. The Alliance Coordinating Office will focus on building and sustaining the Alliance, advising the Government of Canada and the Bill & Melinda Gates Foundation on research gaps, prospecting innovative proposals to respond to identified gaps and promoting synergy between Alliance members.